Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
ID: 357194Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics and data science. This initiative encourages applications that focus on developing novel analytical methodologies, tools, and software that can be broadly applied to enhance human health and disease understanding, with an emphasis on scalable systems for managing complex genomic data. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal colleges, with a maximum budget of $500,000 per year available for projects lasting up to five years. The application submission period opens on January 6, 2025, and closes on September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) is issuing a funding opportunity through the NHGRI for investigator-initiated research in computational genomics and data science. This initiative aims to support projects that foster innovation in the development of novel analytical methodologies, tools, and software that are broadly applicable to human health advancements. The program emphasizes early-stage exploration and the creation of scalable systems for managing complex genomic data. Applicants can submit new, renewal, or resubmission grants, with a maximum budget of $500,000 per year for up to five years. Key dates include an open submission date starting January 6, 2025, and an expiration on September 8, 2027. The proposal should focus on innovative approaches rather than incremental improvements. Eligible organizations for application include higher education institutions and nonprofits, among others. The review process will assess significance, innovation, rigor, and feasibility, ensuring that the projects addressed align with NIH goals for improving genomic research and its applications in health. This funding opportunity represents a strategic investment in the future of genomics and data science, fostering diverse applicant participation and advancing research methodologies.
    Similar Opportunities
    Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" aimed at advancing research in computational genomics, bioinformatics, and data visualization methodologies that enhance genomic science and its application to human health. This initiative seeks innovative projects that develop novel analytical tools and methodologies, with a budget limit of $275,000 for a two-year project period, focusing on scalable solutions applicable across various diseases and biological systems. The funding is particularly targeted at underrepresented entities in genomic research, including higher education institutions, nonprofits, and governmental bodies, reflecting NIH's commitment to fostering collaborative research in this critical field. Interested applicants should note that key submission dates begin on January 16, 2025, with a final expiration date of September 8, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Computational Approaches to Curation at Scale for Biomedical Research Assets" (R01 Clinical Trial Not Allowed) to enhance access to secure and complete biomedical datasets and computational models. The initiative aims to develop innovative computational methodologies that automate curation processes, addressing the increasing demand for curated, FAIR (Findable, Accessible, Interoperable, Reusable) biomedical data essential for data mining and knowledge discovery. Eligible applicants include various institutions such as higher education, nonprofits, and government entities, with a maximum project budget of $250,000 annually for up to four years. Applications are due by 5:00 PM local time, with the first submission window opening on December 27, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Supporting Talented Early Career Researchers in Genomics," aimed at supporting innovative research projects led by Early Stage Investigators (ESIs) with a focus on genomics. This initiative encourages diverse applicants to propose research that aligns with the mission of the National Human Genome Research Institute (NHGRI), covering areas such as genomic sciences, genomic medicine, genomic data science, and the ethical implications of genomics. The program has a funding commitment of at least $2 million, with plans to award 3-5 grants, each with an annual budget cap of $400,000. Applications must be submitted electronically by February 26, 2027, and should include a detailed professional development plan and a resource sharing plan in compliance with NIH policies. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Reuse of NHGRI Data Assets" under the R03 Small Grant Program, aimed at promoting innovative research and secondary analysis projects utilizing genomic datasets from the National Human Genome Research Institute's (NHGRI) AnVIL platform. The initiative seeks to eliminate cost barriers for new users and enhance the utilization of NHGRI datasets, thereby stimulating further discovery in genomics research. Approximately $1 million will be allocated annually for up to seven awards, with each project having a budget limit of $125,000 in direct costs and a maximum project period of two years. Interested applicants must submit their proposals by January 14, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Centers of Excellence in Genomic Science (CEGS) program, aimed at supporting innovative, interdisciplinary research in genomic science. This program seeks to establish academic centers that will develop transformative genomic approaches to address significant biomedical challenges, with a focus on integrating advanced technological and computational methods. Each award can provide up to $1.5 million per year for a maximum of five years, with potential renewal for an additional five years, and applications are due by June 23, 2025. Eligible applicants include a range of institutions such as higher education entities, nonprofits, and various government organizations, while foreign entities are not eligible. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering research grants through the National Library of Medicine (NLM) focused on biomedical informatics and data science, as outlined in funding opportunity announcement PAR-23-034. This initiative aims to support innovative research that enhances biomedical discovery and health data management, emphasizing scalable and reproducible methods that adhere to FAIR standards (Findable, Accessible, Interoperable, Reusable). Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and government agencies, with an annual budget limit of $250,000 over a maximum project period of four years. Interested parties should submit their applications electronically via Grants.gov by January 7, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering small research grants (R03) through the NIDCR for the analysis of existing genomic data related to human dental, oral, and craniofacial biology. The primary objective is to support innovative research projects that utilize statistical and computational methodologies, including artificial intelligence and machine learning, to enhance understanding of diseases and conditions, with a particular emphasis on addressing oral health disparities. This funding opportunity allows for up to $200,000 in direct costs over a two-year period, with applications opening on January 16, 2025, and submissions due by 5 PM local time on May 7, 2026. Interested applicants can find more information and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-166.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the "Supporting Talented Early Career Researchers in Genomics" program, utilizing the R01 activity code. This initiative aims to provide financial support to early career researchers in the field of genomics, facilitating the development of innovative projects that contribute to the understanding of human genetics. The estimated total program funding is $2 million, with an award ceiling of $400,000 per project, and the application period is expected to open on December 18, 2024, with a closing date of February 28, 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is set for December 31, 2025.